CP-673451

Catalog No. A11350

CP 673451 is a potent PDGFR-β inhibitor with an IC50 of 1 nM.
  • Kaori Aoto, .et al. Complex formation between platelet-derived growth factor receptor β and transforming growth factor β receptor regulates the differentiation of mesenchymal stem cells into cancer-associated fibroblasts, Oncotarget, 2018, Sep 25; 9(75): 34090-34102 PMID: 30344924
Catalog Num A11350
M. Wt 417.5
Formula C24H27N5O2
Purity >98%
Storage at -20°C 3 years Powder
CAS No. 343787-29-1
Synonyms CP673451
SMILES COCCOC1=CC2=C(C=C1)N(C=N2)C3=NC4=C(C=CC=C4N5CCC(CC5)N)C=C3
CP 673451 is a potent PDGFR-β inhibitor with an IC50 of 1 nM.
Targets
Target Value
PDGFRβIC50: 1nM
PDGFRαIC50: 10nM
c-KitIC50: 252nM
VEGFR1IC50: 450nM
VEGFR2IC50: 450nM
LCKIC50: >1μM
SrcIC50: >2μM
v-AblIC50: >5μM
Tie-2IC50: >5μM
bFGFRIC50: >5μM
EGFRIC50: >10μM
ErbB2IC50: >10μM
c-MetIC50: >10μM
IGF-1RIC50: >10μM
In vitro DMSO 28 mg/mL heating (67.06 mM)
Water <1 mg/mL (<1 mM)
Ethanol 4 mg/mL (9.58 mM)
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
0.1 mM 23.95 mL 119.76 mL 239.52 mL
0.5 mM 4.79 mL 23.95 mL 47.9 mL
1 mM 2.4 mL 11.98 mL 23.95 mL
5 mM 0.48 mL 2.4 mL 4.79 mL

*The above data is based on the productmolecular weight 417.5. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.